Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

15

Number of overlapping holdings

30.6%

% of FTXH's 50 holdings also in XPH

36.6%

% of XPH's 41 holdings also in FTXH

Overlap by Weight
Sector Drift (FTXH minus XPH)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in FTXH
Weight
in XPH
Overlap
MERCK & CO. INC. 7.2% 4.2% 4.2%
ELI LILLY & CO 3.9% 4.0% 3.9%
JOHNSON & JOHNSON 7.4% 3.8% 3.8%
BRISTOL-MYERS SQUIBB CO 7.1% 3.7% 3.7%
ZOETIS INC 3.6% 4.7% 3.6%

Position Highlights (Non-Overlapping Exposures)
FTXH Overweight Relative to XPH
ABBVIE INC 7.4%
MODERNA, INC. 4.0%
PFIZER INC 3.9%
VERTEX PHARMACEUTICALS INC 3.8%
AMGEN INC 3.7%
REGENERON PHARMACEUTICALS 3.6%
JOHNSON & JOHNSON 3.6%
GILEAD SCIENCES INC 3.5%
BRISTOL-MYERS SQUIBB CO 3.5%
CARDINAL HEALTH INC 3.4%
FTXH Underweight Relative to XPH
REVANCE THERAPEUTICS INC -6.0%
CATALENT INC -5.7%
REATA PHARMACEUTICALS, INC. CLASS A -5.5%
PERRIGO CO -4.1%
ROYALTY PHARMA PLC CLASS A -3.6%
AXSOME THERAPEUTICS, INC. -3.2%
INTRA-CELLULAR THERAPIES INC -3.0%
CASSAVA SCIENCES, INC. -3.0%
AMYLYX PHARMACEUTICALS, INC. -2.8%
ELANCO ANIMAL HEALTH, INC. -2.8%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY